- Open Access
Minimally invasive surgery using intraoperative electron-beam radiotherapy for the treatment of soft tissue sarcoma of the extremities with tendon involvement
World Journal of Surgical Oncology volume 14, Article number: 214 (2016)
When a soft tissue sarcoma (STS) is located at the distal part of an extremity and involves the tendon, a wide excision usually causes severe functional disability. We therefore developed a minimally invasive surgical technique using intraoperative electron-beam radiotherapy (IOERT) to reduce the incidence of post-operative functional disability in patients with peri-/intra-tendinous STS. We assessed the clinical outcomes of the novel minimally invasive surgery.
The study population included five patients who received treatment for distal extremity STSs. After elevating the tumor mass, including the tendon and nerve from the tumor bed with a wide margin, a lead board was inserted beneath the tumor mass to shield the normal tissue. IOERT (25–50 Gy) was then applied, and the tumor excised with care taken to maintain the continuity of the tendon.
In a desmoid patient, local recurrence was observed outside the irradiated field. No cases of neuropathy or bone necrosis were observed. The mean limb function score was excellent in all patients. None of the high-grade sarcoma patients had local recurrence or distant metastasis.
Although the current study is only a pilot study with a small number of patients, it shows that this minimally invasive procedure has the potential to become a standard treatment option for selected patients.
H17-250 (registered 2 November 2005) and H25-250 (modified from H17-250, registered 5 December 2013)
Although the recent progression of multidisciplinary treatments, such as chemotherapy agents, molecular target drugs, and ion beam radiotherapy, have enabled the application of various therapeutic options in the treatment of soft tissue sarcoma (STS), the resection of the tumor with a wide margin is the standard and most reliable treatment for patients with extremity STS [1, 2].
The surgical resection of STS with a wide margin sometimes causes functional disability of the affected limb, because a wide resection requires the excision of adjacent structures, including the bones, nerves, arteries, veins, and tendons [1–4]. The wide excision of even small tumors will usually result in severe functional disability if they are peri-/intra-tendinously located at the distal part of an extremity [1, 3–5]. The active motion of the finger and wrist may be impaired in patients’ forearm tumors. If the tumor is located at the distal leg, the active motion of the toe and ankle may be impaired.
Surgeons have attempted to reduce the degree of functional disability after the resection of peri-/intra-tendinous STSs by various reconstruction methods, including tendon transfers [5, 6], autologous tendon grafts [7–10], allogenic tendon grafts , and functional muscle transfers [3, 4, 6, 7, 12]. However, these procedures require the muscle to act as a power source, and muscle function may disappear after a wide excision [4, 7, 12]. Tendon transfer causes severe soft tissue adhesion due to the sub-optimal condition of the tissue bed after resection . Although a tendon graft may be a treatment option, the harvest of the tendon results in surgical stress at the donor site [7, 11]. The clinical outcome of the reconstruction of the soft tissue defect should be measured not only by stable wound coverage but also by preservation of a patient’s limb function . However, the impact of reconstructive surgery has been limited .
External-beam radiation therapy (EBRT) given before or after surgery is the standard treatment, especially in high-grade (G2–3), deep, and less than 5-cm lesions . Preoperative EBRT is associated with lower rates of late toxicity and may allow a lower radiation dose, because the intact vascular supply renders a tumor more sensitive to RT. Post-operative EBRT is typically administered at 60–68 Gy over 6 to 7 weeks. Advantages of post-operative EBRT include the availability to conduct a full pathological review of the tumor prior to making a decision about adjuvant therapy. However, the most critical problem associated with EBRT is that it can cause a number of common, well-described side effects, such as muscle fibrosis, severe neuropathy, joint contracture, vascular obstruction, and lymphatic edema [14, 15]. These adverse effects of EBRT sometimes compromise the quality of life of patients.
Intraoperative radiotherapy (IORT) was first performed by Abe et al. at Kyoto University in the early 1960s . IORT is designed to provide a large radiation dose to a target tissue while sparing normal tissues. Intraoperative electron-beam radiotherapy (IOERT) refers to the application of electron-beam radiation in this procedure. The therapeutic advantage is that IOERT can deliver a highly effective radiation dose to a specific target, while the dose to healthy structures can be limited by surgical displacement or shielding . There is a large amount of published work on the use of IOERT in combination with surgery with/without EBRT in the treatment of soft tissue sarcomas of the retroperitoneum or extremities [14, 18–27]. The typical IOERT doses range from 10 to 20 Gy. Doses of 10–12.5 Gy are often used for patients with microscopic residual or close margins. However, for patients with gross residual disease, higher doses of up to 20 Gy are used. Recently, the combination of IOERT and EBRT has been recommended and many institutes perform IOERT (15 to 20 Gy) followed by EBRT (35 to 50 Gy) after surgery . The 5-year local control rates in patients with retroperitoneal STSs and extremity STSs were reported to be 40–65 % [22, 24, 25] and 63–91 % [14, 17–21, 27, 28], respectively.
Although conventional IOERT has been used to achieve limb preservation without local recurrence, the improvement of limb function has not usually been considered in the assessment of treatment outcomes. We therefore developed a minimally invasive surgical technique using IOERT to reduce the incidence of post-operative functional disability in patients with peri-/intra-tendinous STS.
This surgical procedure consists of the four following steps: 1) the elevation of the tumor mass including the tendon and nerve from the tumor bed with a wide margin, 2) IOERT after the insertion of a lead board beneath the tumor mass to shield the normal tissue, 3) tumor excision maintaining the continuity of the tendon, and if necessary, 4) reconstruction of the soft tissue defect using a vascularized/local musculocutaneous flap. The purpose of the present study is to clarify the clinical outcomes of this novel surgical technique.
Five patients with peri-/intra-tendinous STSs of the distal extremities underwent surgical treatment in combination with IOERT (Table 1). All of the patients were female. The mean age of the patients was 32 years (range 14–62 years). The mean follow-up period was 50 months (range 27–67 months). The tumors were located intra-tendinously in three cases and peri-tendinously with adhesion to the tendon in two cases. No patients had distant metastasis. The mean tumor size was 3.1 cm (range 0.7–4 cm). The histological diagnoses were clear cell sarcomas (n = 2) and synovial sarcoma (n = 1), desmoid (n = 1), and myxofibrosarcoma (n = 1). The involved tendons were flexor/extensor of the distal forearm (n = 2), the calcaneal tendons (n = 2), and the tibialis posterior tendon (n = 1). Two of five operations were additional excisions after intra-lesional resection at another hospital. One desmoid patient was a recurrent case who had undergone three previous surgeries. Adjuvant chemotherapy was performed in cases 2 and 3. The study was performed in accordance with the ethical standards of the institutional responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983. All patients provided written informed consent before enrolment in the study.
Surgical procedures, IOERT, and post-operative management
The lesion was isolated and separated from the normal tissues in the axial plane with a wide surgical margin, maintaining the continuity of proximal and distal normal tissue. After the elevation of the tumor mass, including the tendon and nerve, from the tumor bed, 6-mm-thick lead boards, which were covered with a sterile drape, were inserted beneath the tumor mass to shield the normal tissue (Fig. 1a). The wet gauze was used as a layer of low density material to protect the braking X-ray. The patients were transferred to the radiotherapy department after the affected limbs were wrapped in sterilized plastic bags (Fig. 1b), and 25–50 Gy of 12 MeV electrons were delivered by a linear accelerator (Novalis TX, Brain LAB, Feldkirchen, Germany). Using the linear-quadratic (LQ) model (assuming an alpha/beta of three for the normal soft tissue surrounding the tumor), a single dose of 25, 35, and 50 Gy corresponded to an equivalent dose in 2-Gy fractions (EQD2) of 140, 266, and 530 Gy, respectively . An appropriately sized cone was used to obtain a 3-cm longitudinal safety-margin for the irradiation field. After irradiation, the patients were returned to the operation room, and underwent the marginal/intra-lesional resection of the tumor, preserving the tendon and nerve (Fig. 1c) under general anesthesia. When the muscle was included in the irradiation field, the muscle was resected as much as possible. If necessary, the soft tissue defect was then reconstructed using a pedicled or free musculocutaneous flap (Fig. 1d).
After the operation, all of the patients were kept immobilized with the extremity in a bulky dressing for the first 12 h. Thereafter, the patients started a gentle active range of motion (ROM) exercise. Extensive rehabilitation was started after confirming the survival of the flap on post-operative day 10. Full weight bearing was permitted at 3 weeks after surgery in cases 2, 3, and 4.
The complications, local recurrence, oncological result, and functional outcome were evaluated. The functional assessments were performed using the Musculoskeletal Tumor Society (MSTS) scoring system . The Radiation Therapy Oncology Group (RTOG) criteria were used to analyze the toxicity .
In all of the cases, an appropriately sized cone was used to obtain a 2-cm longitudinal safety-margin for the irradiation field. After irradiation, the tumor was surgically resected with the marginal margin (case 4) or intra-lesional margin (cases 1, 2, 3, and 5) (Table 2). The median follow-up period was 56 months (range 27–67 months).
For one desmoid patient, the entire operation was performed under general anesthesia (case 1). A patient whose tumor was located at the forearm (case 5) started the procedure under a supraclavicular brachial plexus block, and the procedure was started under lumbar anesthesia in three patients with leg tumors (cases 2, 3, and 4). However, after the patients returned to the operation room following the IOERT, the tumor resection and reconstruction of the soft tissue defect were performed under general anesthesia. A free vascularized latissimus dorsi flap was used to reconstruct the soft tissue defect in cases 2, 3 and 5; a localized pedicle musculocutaneous flap was used in case 4. A patient with synovial sarcoma of the distal leg, who received additional excision after inadequate resection at the initial hospital (case 3), showed partial necrosis of the free vascularized latissimus dorsi flap and required secondary minor suturing.
Local recurrence was observed at the region outside of the irradiated field in the desmoid patient (case 1). Case 2 incidentally underwent an incisional biopsy of the calcaneal tendon at 61 months after the operation because she hoped to have cosmetic surgery to improve the appearance of operation site. A pathological examination showed that the patient was recurrence-free and also demonstrated the regeneration of the tenocytes of the irradiated calcaneal tendon. None of sarcoma patients had local recurrence or distant metastasis.
Cases 1 and 5 showed post-operative restricted ROM of the wrist joints; however, the restriction was mild (RTOG criteria: grade 1). No cases of neuropathy, bone necrosis, vascular obstruction, and lymphatic edema were observed.
The mean limb function scores, which were determined according to the MSTS scoring system, were 87 % in the patients with a tumor of the upper extremities and 100 % in the patients with a tumor of the lower extremities.
The surgical excision of sarcomas involving the tendons sometimes leads to severe functional disability [1, 4–6]. We showed the successful clinical outcomes of minimally invasive surgery using IOERT for extremity STS involving the tendon. Although the current study is only a pilot study with a small number of patients, the results show that the procedure has the potential to become a standard minimally invasive therapy for selected patients.
IOERT has several advantages over traditional EBRT. It allows the radiotherapist to create a highly conformal treatment field. It also allows for the delivery of higher doses than EBRT because it is less toxic to the normal tissue [17, 23, 26, 28, 31–34]. In conventional IOERT, the electron beam is delivered (with the surrounding normal tissue shielded by a lead cone) to the affected site after the excision of the tumor with a marginal, intra-lesional, or wide margin. The most important point of the current study is that the IOERT was applied to salvage the tendon prior to the resection of the peri-/intra-tendinous tumor. In the current study, IOERT was delivered with a wide margin, and the surrounding tissue was completely shielded with a lead board and applicator; the tumor was then excised with a marginal or intra-lesional margin. Thus, the current surgical procedure should be distinguished from conventional IOERT, which is applied after the resection of the tumor with an aim of reducing local recurrence.
There are few reports on the use of IORT as a minimally invasive treatment of the affected limb in patients with localized sarcoma. A group at Kyoto University first reported the application of IORT for extremity osteosarcoma [35, 36]. The lesion was isolated and separated from the normal tissues with a wide margin in the axial plane, maintaining the continuity of the proximal and distal normal tissue, and irradiation (45–70 Gy) was administered with an electron beam (12–30 MeV) or X-rays (10 MV). The irradiated tumor was generally left without excision. Twelve of 33 patients showed post-operative local recurrence. However, only one of the 12 patients showed recurrence in the irradiated field. The concept of the clinical study performed at Kyoto University was identical to our current study.
The biological effectiveness of delivering a dose in a single fraction is not completely understood. The tool most commonly used for the quantitative prediction of dose/fractionation dependencies in radiotherapy is the mechanistically based LQ model . Using the LQ model and assuming an alpha/beta of three for the normal soft tissue surrounding a tumor, a single dose of 25 Gy corresponded to an EQD2 of 140 Gy. None of the sarcoma patients had local recurrences or distant metastasis. In case 2, the examination of a biopsy sample confirmed the absence of recurrence. Thus, 35–50 Gy might have been a radical dose in the current series. Further study and a long-term follow-up period are warranted.
The IOERT dose was carefully determined, so that it would achieve a biological cure while minimizing the damage to the soft tissue, such as the muscle, tendons, and peripheral nerves [37–40]. The adverse effects on the muscle were most critical, since IOERT was not applied to lesions that included a major nerve (such as the sciatic nerve or brachial plexus) in the current series. Radiation-induced muscle injury was characterized by a loss of muscle fiber, decreased fiber size, severe vessel lesions, hemorrhage, inflammation, coagulation necrosis, and fibrosis [37, 39]. In the context of clinical studies, IOERT is usually combined with EBRT with a dose range of 10–12 Gy for R0-R1 resections and 15–20 Gy for R2 resections (gross macroscopic residual disease) [37–40]. In the current series, case 5 showed mildly restricted ROM of the wrist joints. Because this patient underwent IOERT during additional wide excision after unplanned tumor resection, the flexor muscle of the distal forearm was included in the irradiation field to avoid recurrence in the contaminated area. However, the radiation-induced muscle injury did not cause any significant functional disability even in case 5, because the tumors were located at the distal extremities, which include only a small amount of muscle fiber. Furthermore, the muscle fiber included in the irradiation field was resected as much as possible. These findings suggest that this surgical procedure should be indicated only for tumors located in the distal extremities.
In our institute, it was necessary to transfer the patient from the operation room to the radiation treatment room. This process requires close cooperation between nursing staff, anesthesiologists, surgeons, and radiation oncology staff. To reduce the complications of IOERT, lumbar anesthesia/scalene block anesthesia was administered until the patients returned from the radiation treatment room (with the exception of one pediatric patient; case 1). The radiation oncologist and surgeons could therefore maintain direct visual and video contact with the patient. To ensure the smooth performance of this complicated procedure, it is recommended that it be thoroughly discussed with the anesthesiologist prior to surgery.
In one patient (case 1), local recurrence was observed outside of the irradiated field. This patient had a desmoid tumor which recurred three times after resection. Thus, the recurrence of this case was not due to the current surgical procedure; rather, it was due the pathological character of the desmoid tumor. Case 1 showed the restricted ROM of the wrist joints after surgery due to repeated surgery for desmoid tumors. The most critical problem associated with conventional EBRT is that it often causes a number of common, well-described side effects, such as severe muscle fibrosis, neuropathy, joint contracture, vascular obstruction, and lymphatic edema . These adverse effects of EBRT sometimes compromise the quality of life of patients. However, in the current series of patients who underwent IOERT, no severe complications were observed. A long-term follow-up study is warranted.
Because the margin status is reported to be the most important prognostic factor for the local control of STS, the elevation of the tumor mass with a completely negative margin from the surrounding tissue is necessary before IOERT is administered. Thus, this surgical procedure must be carefully indicated for selected patients.
When an STS involving a tendon is located at the distal part of an extremity, a wide excision usually results in severe functional disability. We therefore developed a minimally invasive surgical technique using IOERT to reduce the incidence of post-operative functional disability in patients with peri-/intra-tendinous STS. IOERT was delivered with a wide margin under the complete shield of the surrounding tissue using a lead board and applicator. The tumor was then excised with a marginal or intra-lesional margin maintaining the tendon continuity. We showed the successful clinical outcomes of this minimally invasive surgery.
Although the current study is only a pilot study with a small number of patients, it has the potential to become a standard therapy for selected patients. A further study with a long-term follow-up period is necessary.
EBRT, external-beam radiation therapy; IOERT, intraoperative electron-beam radiotherapy; IORT, intraoperative radiotherapy; MSTS, Musculoskeletal Tumor Society; ROM, range of motion; RTOG, Radiation Therapy Oncology Group; STS, soft tissue sarcoma
Steinau HU, Daigeler A, Langer S, Steinsträsser L, Hauser J, Goertz O, et al. Limb salvage in malignant tumors. Semin Plast Surg. 2010;24:18–33.
ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment andfollow-up. Ann Oncol. 2014;25 Suppl 3:iii102–12.
Talbot SG, Mehrara BJ, Disa JJ, Wong AK, Pusic A, Cordeiro PG, et al. Soft-tissue coverage of the hand following sarcoma resection. Plast Reconstr Surg. 2008;121:534–43.
Saint-Cyr M, Langstein HN. Reconstruction of the hand and upper extremity after tumor resection. J Surg Oncol. 2006;94:490–503.
Fischer S, Soimaru S, Hirsch T, Kueckelhaus M, Seitz C, Lehnhardt M, et al. Local tendon transfer for knee extensor mechanism reconstruction after soft tissue sarcoma resection. J Plast Reconstr Aesthet Surg. 2015;68:729–35.
Muramatsu K, Ihara K, Yoshida K, Tominaga Y, Hashimoto T, Taguchi T. Musculoskeletal sarcomas in the forearm and hand: standard treatment and microsurgical reconstruction for limb salvage. Anticancer Res. 2013;33:4175–82.
Germann G, Waag KL, Selle B, Jester A. Extremity salvage with a free musculocutaneous latissimus dorsi flap and free tendon transfer after resection of a large congenital fibrosarcoma in a 15-week-old infant. A case report. Microsurgery. 2006;26:429–31.
Lidman D, Nettelblad H, Berggren A, Rajan S. Reconstruction of soft tissue defects including the Achilles tendon with free neurovascular tensor fascia lata flap and fascia lata. Case report. Scand J Plast Reconstr Surg Hand Surg. 1987;21:213–8.
Omori S, Hamada K, Outani H, Oshima K, Joyama S, Tomita Y, et al. Intraoperative extracorporeal autogenous irradiated tendon grafts for functional limb salvage surgery of soft tissue sarcomas of the wrist and hand. World J Surg Oncol. 2015;13:179.
Ozaki R, Hamada K, Emori M, Omori S, Joyama S, Naka N, et al. Limb salvage operation using intraoperative extracorporeal autogenous irradiated bone and tendon graft for myxoid liposarcoma on dorsum of foot. Foot (Edinb). 2010;20:90–5.
Yuen JC, Nicholas R. Reconstruction of a total Achilles tendon and soft-tissue defect using an Achilles allograft combined with a rectus muscle free flap. Plast Reconstr Surg. 2001;107:1807–11.
Payne CE, Hofer SO, Zhong T, Griffin AC, Ferguson PC, Wunder JS. Functional outcome following upper limb soft tissue sarcoma resection with flap reconstruction. J Plast Reconstr Aesthet Surg. 2013;66:601–7.
Heiner J, Rao V, Mott W. Immediate free tissue transfer for distal musculoskeletal neoplasms. Ann Plast Surg. 1993;30:140–6.
Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004;60:265–74.
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.
Abe M, Takahashi M. Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys. 1981;7:863–8.
Valentini V, Balducci M, Tortoreto F, Morganti AG, De Giorgi U, Fiorentini G. Intraoperative radiotherapy: current thinking. Eur J Surg Oncol. 2002;28:180–5.
Kretzler A, Molls M, Gradinger R, Lukas P, Steinau HU, Würschmidt F. Intraoperative radiotherapy of soft tissue sarcoma of the extremity. Strahlenther Onkol. 2004;180:365–70.
Calvo FA, Sole CV, Polo A, Cambeiro M, Montero A, Alvarez A, et al. Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy boost for patients with primary soft tissue sarcoma of the extremity: a multicentric pooled analysis of long-term outcomes. Strahlenther Onkol. 2014;190:891–8.
Call JA, Stafford SL, Petersen IA, Haddock MG. Use of intraoperative radiotherapy for upper-extremity soft-tissue sarcomas: analysis of disease outcomes and toxicity. Am J Clin Oncol. 2014;37:81–5.
Sole CV, Calvo FA, Polo A, Cambeiro M, Alvarez A, Gonzalez C, et al. Anticipated intraoperative electron beam boost, external beam radiation therapy, and limb-sparing surgical resection for patients with pediatric soft-tissue sarcomas of the extremity: a multicentric pooled analysis of long-term outcomes. Int J Radiat Oncol Biol Phys. 2014;90:172–80.
Stucky CC, Wasif N, Ashman JB, Pockaj BA, Gunderson LL, Gray RJ. Excellent local control with preoperative radiation therapy, surgical resection, and intra-operative electron radiation therapy for retroperitoneal sarcoma. J Surg Oncol. 2014;109:798–803.
Miller ED, Xu-Welliver M, Haglund KE. The role of modern radiation therapy in the management of extremity sarcomas. J Surg Oncol. 2015;111:599–603.
Sweeting RS, Deal AM, Llaguna OH, Bednarski BK, Meyers MO, Yeh JJ, et al. Intraoperative electron radiation therapy as an important treatment modality in retroperitoneal sarcoma. J Surg Res. 2013;185:245–9.
Niewald M, Fleckenstein J, Licht N, Bleuzen C, Ruebe C. Intraoperative radiotherapy (IORT) combined with external beam radiotherapy (EBRT) for soft-tissue sarcomas—a retrospective evaluation of the Homburg experience in the years 1995-2007. Radiat Oncol. 2009;26; 4:32.
Oertel S, Treiber M, Zahlten-Hinguranage A, Eichin S, Roeder F, Funk A, et al. Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2006;64:1416–23.
Azinovic I, Martinez Monge R, Javier Aristu J, Salgado E, Villafranca E, Fernandez Hidalgo O, et al. Intraoperative radiotherapy electron boost followed by moderate doses of external beam radiotherapy in resected soft-tissue sarcoma of the extremities. Radiother Oncol. 2003;67:331–7.
Debenham BJ, Hu KS, Harrison LB. Present status and future directions of intraoperative radiotherapy. Lancet Oncol. 2013;14:e457–64.
Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol. 2008;18:234–9.
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241–6.
Willett CG, Czito BG, Tyler DS. Intraoperative radiation therapy. J Clin Oncol. 2007;25:971–7.
Ellis RJ, Kim E, Kinsella TJ, Eisenberg BL. Intraoperative radiotherapy in the multimodality approach to bone and soft tissue cancers. Surg Oncol Clin N Am. 2003;12:1015–29.
Hu KS, Harrison LC. Adjuvant radiation therapy of retroperitoneal sarcoma: the role of intraoperative radiotherapy (IORT). Sarcoma. 2000;4:11–6.
DeLaney TF, Trofimov AV, Engelsman M, Suit HD. Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas. Cancer Control. 2005;12:27–35.
Oya N, Kokubo M, Mizowaki T, Shibamoto Y, Nagata Y, Sasai K, et al. Definitive intraoperative very high-dose radiotherapy for localized osteosarcoma in the extremities. Int J Radiat Oncol Biol Phys. 2001;51:87–93.
Tsuboyama T, Toguchida J, Kotoura Y, Kasahara K, Hiraoka M, Nakamura T. Intra-operative radiation therapy for osteosarcoma in the extremities. Int Orthop. 2000;24:202–7.
Powers BE, Gillette EL, Gillette SL, LeCouteur RA, Withrow SJ. Muscle injury following experimental intraoperative irradiation. Int J Radiat Oncol Biol Phys. 1991;20:463–71.
Vujaskovic Z, Gillette SM, Powers BE, LaRue SM, Gillette EL, Borak TB, et al. Intraoperative radiation (IORT) injury to sciatic nerve in a large animal model. Radiother Oncol. 1994;30:133–9.
An Kampen M, Eble MJ, Lehnert T, Bernd L, Jensen K, Hensley F, et al. Correlation of intraoperatively irradiated volume and fibrosis in patients with soft-tissue sarcoma of the extremities. Int J Radiat Oncol Biol Phys. 2001;51:94–9.
Azinovic I, Calvo FA, Puebla F, Aristu J, Martínez-Monge R. Long-term normal tissue effects of intraoperative electron radiation therapy (IOERT): late sequelae, tumor recurrence, and second malignancies. Int J Radiat Oncol Biol Phys. 2001;49:597–604.
We thank the secretarial staffs of the department for their generous cooperation.
This study was funded by The Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour, and Welfare (H26-084).
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
AM and MT developed the surgical procedure, designed the study, and drafted the manuscript. TM, KA, TM, TK, and YY analyzed the clinical data. AT, NI, and YN developed the procedure of IOERT as radiologists and carefully decided the irradiated dose. AS advised to make a well-designed study protocol and contributed to the writing of the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
All patients provided written informed consent before enrolment in the study.
Ethics approval and consent to participate
The study was performed in accordance with the ethical standards of the institutionally responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983. All patients provided written informed consent before enrolment in the study.
About this article
Cite this article
Matsumine, A., Tsujii, M., Nakamura, T. et al. Minimally invasive surgery using intraoperative electron-beam radiotherapy for the treatment of soft tissue sarcoma of the extremities with tendon involvement. World J Surg Onc 14, 214 (2016). https://doi.org/10.1186/s12957-016-0968-4
- Minimally invasive surgery
- Intraoperative electron-beam radiotherapy (IOERT)
- Soft tissue sarcoma
- Tendon involvement
- Clinical outcome